Glutathione reduced ethyl ester
CAS: 118421-50-4
Ref. 3D-FG03344
1g | 693,00 € | ||
2g | 1.071,00 € | ||
5g | 2.142,00 € | ||
250mg | 297,00 € | ||
500mg | 450,00 € |
Informação sobre produto
- GSH-MEE Glutathione Monoethyl Ester gamma-Glu-Cys-Gly-OEt
- Glutathione monoethyl ester
- Glycine, <span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl-, monoethyl ester
- Glycine, N-(N-<span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl)-, monoethyl ester
- Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-, monoethyl ester
- Ione Ethyl Ester
- N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester
- ethyl L-gamma-glutamyl-L-cysteinylglycinate
- Glycine, N-(N-L-γ-glutamyl-L-cysteinyl)-, monoethyl ester
- Glycine, L-γ-glutamyl-L-cysteinyl-, monoethyl ester
- Ver mais sinónimos
Glutathione reduced ethyl ester (GR-E) is a potential anticancer drug that binds to the DNA and induces reactive oxygen species. GR-E has been shown to have minimal toxicity in vivo, with no observable adverse effects on the liver. GR-E has also been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has also been shown to bind to toll-like receptor 2, which may lead to an antiinflammatory response.
Propriedades químicas
Consulta técnica sobre: 3D-FG03344 Glutathione reduced ethyl ester
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.